dual PD-1/PD-L1 immune checkpoint inhibitors (Southern Medical University)

N/A

Report date: 2025/01/26 18:33:45
NME

Base Information

Drug Namedual PD-1/PD-L1 immune checkpoint inhibitors (Southern Medical University)
Drug Alias Namedual PD-1 checkpoint inhibitor/PD-L1 checkpoint inhibitor (Southern Medical University)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProgrammed cell death protein 1 blockersProgrammed death-ligand 1 blockers
TargetsProgrammed death-ligand 1Programmed cell death protein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSouthern Medical University, China
China Registration ClassN/A

Develop Information

Active CompaniesSouthern Medical University, China
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A